Challenges to Using Big Data in Cancer
Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams et al. · Cancer Research · 2023
Big data in healthcare can enable unprecedented understanding of diseases and their treatment, particularly in oncology. These data may include electronic health records, medical imaging, genomic sequencing, payor records, and data from pharmaceutical research, wearables, and medical devices. The ability to combine datasets and use data across many analyses is critical to the successful use of big data and is a concern for those who generate and use the data. Interoperability and data quality continue to be major challenges when working with different healthcare datasets. Mapping terminology across datasets, missing and incorrect data, and varying data structures make combining data an onerous and largely manual undertaking. Data privacy is another concern addressed by the Health Insurance Portability and Accountability Act, the Common Rule, and the General Data Protection Regulation. The use of big data is now included in the planning and activities of the FDA and the European Medicines Agency. The willingness of organizations to share data in a precompetitive fashion, agreements on data quality standards, and institution of universal and practical tenets on data privacy will be crucial to fully realizing the potential for big data in medicine.
Cited by 65 works. doi:10.1158/0008-5472.can-22-1274 Open-access PDF
Authors
- Shawn M. Sweeney
- Hisham K. Hamadeh
- Natalie Abrams
- Stacey J. Adam
- Sara Brenner
- Dana E. Connors
- Gerard J. Davis
- Louis D. Fiore
- Susan H. Gawel
- Robert L. Grossman
- Sean E. Hanlon
- Karl Hsu
- Gary J. Kelloff
- Ilan Richard Kirsch
- Bill Louv
- Deven McGraw
- Frank Meng
- Daniel Milgram
- Robert Stephen Miller
- Emily Morgan
References
- Cramming More Components onto Integrated Circuits (1965)
- The Learning Healthcare System: Workshop Summary
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; other modifications to the HIPAA rules.
- Routes for breaching and protecting genetic privacy
- Federal Policy for the Protection of Human Subjects. Final rule.
- Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
- Harnessing multimodal data integration to advance precision oncology
- Real-world data: towards achieving the achievable in cancer care
- Feasibility of Reidentifying Individuals in Large National Physical Activity Data Sets From Which Protected Health Information Has Been Removed With Use of Machine Learning